Grade My Investments
Home › Free Stock Grades › CNTB

Connect Biopharma Holdings Limited (CNTB) Stock Grade

CNTB · Healthcare

C-
Grade updated: September 29, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$68.0M
P/E Ratio
—
Revenue Growth (YoY)
-99.8%
Net Margin
-86687.5%
Return on Equity
—
Dividend Yield
None

About Connect Biopharma Holdings Limited's fundamentals

Connect Biopharma Holdings Limited is a biotechnology company with a market capitalization of $68.0 million that reported a net loss in its latest annual statement. The company experienced severe revenue decline, with year-over-year revenue growth of -99.8%, indicating a near-complete collapse in sales. With a net margin of -86,687.5%, the company is losing substantially more money than any revenue it generates, and it does not currently pay a dividend.

Track CNTB free — no credit card required. Live grade + monthly AI report →